CAR-T cells—Real-time experience applying CAR-T cells—What we have learned so far

被引:0
|
作者
Hildegard Greinix
机构
[1] Medical University of Graz,Clinical Division of Hematology
来源
memo - Magazine of European Medical Oncology | 2022年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:173 / 175
页数:2
相关论文
共 50 条
  • [2] CAR-T cells: the Chinese experience
    Wang, Linqin
    Tan Su Yin, Elaine
    Zhao, Houli
    Ni, Fang
    Hu, Yongxian
    Huang, He
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (11) : 1293 - 1308
  • [3] CAR-T Cells
    Maloney, David G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S100 - S101
  • [4] Real time experience applying CAR T-cells for B-cell lymphoma—What we have learned so far: Acute toxicity management
    Emine Kaynak
    Johannes Clausen
    memo - Magazine of European Medical Oncology, 2022, 15 : 180 - 184
  • [5] Real time experience applying CAR T-cells for B-cell lymphoma-What we have learned so far: Acute toxicity management
    Kaynak, Emine
    Clausen, Johannes
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (03) : 180 - 184
  • [6] The CAR-T cells are here
    Croizier, Carolyne
    Douge, Aurore
    Bay, Jacques-Olivier
    Lemal, Richard
    BULLETIN DU CANCER, 2018, 105 (09) : 743 - 745
  • [7] Engineering CAR-T cells
    Zhang, Cheng
    Liu, Jun
    Zhong, Jiang F.
    Zhang, Xi
    BIOMARKER RESEARCH, 2017, 5
  • [8] Engineering CAR-T cells
    Cheng Zhang
    Jun Liu
    Jiang F. Zhong
    Xi Zhang
    Biomarker Research, 5
  • [9] CAR-T cells: What are the prospects and options for their use?
    Hauet, Thierry
    Facon, Thierry
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (08): : 1017 - 1018
  • [10] CAR-T cells for cancer immunotherapy
    Xie, Yangyang
    Li, Xiaotong
    Wu, Jingyi
    Zeng, Huiling
    Boucetta, Hamza
    Wang, Binru
    Yang, Pei
    He, Wei
    CHINESE CHEMICAL LETTERS, 2023, 34 (09)